Table of Contents
International Journal of Brain Science
Volume 2014 (2014), Article ID 652643, 9 pages
http://dx.doi.org/10.1155/2014/652643
Research Article

Could Upregulated Hsp70 Protein Compensate for the Hsp90-Silence-Induced Cell Death in Glioma Cells?

Brain Tumour North West, Faculty of Science and Technology, University of Central Lancashire, Preston PR1 2HE, UK

Received 13 May 2013; Accepted 19 September 2013; Published 2 January 2014

Academic Editor: Toshio Matsuda

Copyright © 2014 Chinmay Munje et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Shervington, N. Cruickshanks, R. Lea, G. Roberts, T. Dawson, and L. Shervington, “Can the lack of HSP90α protein in brain normal tissue and cell lines, rationalise it as a possible therapeutic target for gliomas?” Cancer Investigation, vol. 26, no. 9, pp. 900–904, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Altieri, “Coupling apoptosis resistance to the cellular stress response: the IAP-Hsp90 connection in cancer,” Cell Cycle, vol. 3, no. 3, pp. 255–256, 2004. View at Google Scholar · View at Scopus
  3. L. Neckers, “Heat shock protein 90: the cancer chaperone,” Journal of Biosciences, vol. 32, no. 3, pp. 517–530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. E. Cowen and S. Lindquist, “Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi,” Science, vol. 309, no. 5744, pp. 2185–2189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. B. K. Eustace, T. Sakurai, J. K. Stewart et al., “Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness,” Nature Cell Biology, vol. 6, no. 6, pp. 507–514, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Rodina, M. Vilenchik, K. Moulick et al., “Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer,” Nature Chemical Biology, vol. 3, no. 8, pp. 498–507, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Cruickshanks, L. Shervington, R. Patel, C. Munje, D. Thakkar, and A. Shervington, “Can hsp90α-targeted siRNA combined with TMZ be a future therapy for glioma?” Cancer Investigation, vol. 28, no. 6, pp. 608–614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Oehler, B. Schmierer, M. Zellner, R. Prohaska, and E. Roth, “Endothelial cells downregulate expression of the 70 kDa heat shock protein during hypoxia,” Biochemical and Biophysical Research Communications, vol. 274, no. 2, pp. 542–547, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Lanneau, A. de Thonel, S. Maurel, C. Didelot, and C. Garrido, “Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27,” Prion, vol. 1, no. 1, pp. 53–60, 2007. View at Google Scholar · View at Scopus
  10. N. A. Seidberg, R. S. B. Clark, X. Zhang et al., “Alterations in inducible 72-kDa heat shock protein and the chaperone cofactor BAG-1 in human brain after head injury,” Journal of Neurochemistry, vol. 84, no. 3, pp. 514–521, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. K. Calderwood, J. R. Theriault, and J. Gong, “Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity,” European Journal of Immunology, vol. 35, no. 9, pp. 2518–2527, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Schmitt, M. Gehrmann, M. Brunet, G. Multhoff, and C. Garrido, “Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 15–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Nylandsted, K. Brand, and M. Jäättelä, “Heat shock protein 70 is required for the survival of cancer cells,” Annals of the New York Academy of Sciences, vol. 926, pp. 122–125, 2000. View at Google Scholar · View at Scopus
  14. S. K. Calderwood, M. A. Khaleque, D. B. Sawyer, and D. R. Ciocca, “Heat shock proteins in cancer: chaperones of tumorigenesis,” Trends in Biochemical Sciences, vol. 31, no. 3, pp. 164–172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Frese, M. Schaper, J.-R. Kuster et al., “Cell death induced by down-regulation of heat shock protein 70 in lung cancer cell lines is p53-independent and does not require DNA cleavage,” Journal of Thoracic and Cardiovascular Surgery, vol. 126, no. 3, pp. 748–754, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Pocaly, V. Lagarde, G. Etienne et al., “Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia,” Leukemia, vol. 21, no. 1, pp. 93–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Kaur, J. Kaur, and R. Ralhan, “Induction of apoptosis by abrogation of HSP70 expression in human oral cancer cells,” International Journal of Cancer, vol. 85, no. 1, pp. 1–5, 2000. View at Google Scholar
  18. S. Sato, N. Fujita, and T. Tsuruo, “Modulation of Akt kinase activity by binding to Hsp90,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 20, pp. 10832–10837, 2000. View at Google Scholar · View at Scopus
  19. M. D. Siegelin, A. Habel, and T. Gaiser, “17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis,” Neurobiology of Disease, vol. 33, no. 2, pp. 243–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. W. Schulte, W. G. An, and L. M. Neckers, “Geldanamycin-induced destabilization of Raf-1 involves the proteasome,” Biochemical and Biophysical Research Communications, vol. 239, no. 3, pp. 655–659, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. W. G. An, T. W. Schulte, and L. M. Neckers, “The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210(bcr-abl) and v-src proteins before their degradation by the proteasome,” Cell Growth and Differentiation, vol. 11, no. 7, pp. 355–360, 2000. View at Google Scholar · View at Scopus
  22. K. S. Bisht, C. M. Bradbury, D. Mattson et al., “Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro & in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity,” Cancer Research, vol. 63, no. 24, pp. 8984–8995, 2003. View at Google Scholar · View at Scopus
  23. M. K. Hadden, D. J. Lubbers, and B. S. J. Blagg, “Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site,” Current Topics in Medicinal Chemistry, vol. 6, no. 11, pp. 1173–1182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Burger, H.-H. Fiebig, S. F. Stinson, and E. A. Sausville, “17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models,” Anti-Cancer Drugs, vol. 15, no. 4, pp. 377–387, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Braga-Basaria, E. Hardy, R. Gottfried, K. D. Burman, M. Saji, and M. D. Ringel, “17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2982–2988, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M.-E. Sauvageot, J. L. Weatherbee, S. Kesari et al., “Effcacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells,” Neuro-Oncology, vol. 11, no. 2, pp. 109–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. D. Dittmar and W. B. Pratt, “Folding of the glucocorticoid receptor by the reconstituted hsp90-based chaperone machinery. The initial hsp90·p60·hsp70-dependent step is sufficient for creating the steroid binding conformation,” Journal of Biological Chemistry, vol. 272, no. 20, pp. 13047–13054, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Morishima, P. J. M. Murphy, D.-P. Li, E. R. Sanchez, and W. B. Pratt, “Stepwise assembly of a glucocorticoid receptor·hsp90 heterocomplex resolves two sequential ATP-dependent events involving first hsp70 and then hsp90 in opening of the steroid binding pocket,” The Journal of Biological Chemistry, vol. 275, no. 24, pp. 18054–18060, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Google Scholar · View at Scopus
  30. H.-C. Wang, C.-S. Liu, C.-F. Chiu et al., “Significant association of DNA repair gene Ku80 genotypes with breast cancer susceptibility in Taiwan,” Anticancer Research, vol. 29, no. 12, pp. 5251–5254, 2009. View at Google Scholar · View at Scopus
  31. S. Martin, E. C. Cosset, J. Terrand, A. Maglott, K. Takeda, and M. Dontenwill, “Caveolin-1 regulates glioblastoma aggressiveness through the control of α5β1 integrin expression and modulates glioblastoma responsiveness to SJ749, an α5β1 integrin antagonist,” Biochimica et Biophysica Acta, vol. 1793, no. 2, pp. 354–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Kreth, J. Heyn, S. Grau, H. A. Kretzschmar, R. Egensperger, and F. W. Kreth, “Identification of valid endogenous control genes for determining gene expression in human glioma,” Neuro-Oncology, vol. 12, no. 6, pp. 570–579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Shirahata, K. Iwao-Koizumi, S. Saito et al., “Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis,” Clinical Cancer Research, vol. 13, no. 24, pp. 7341–7356, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-I. Yokota, M. Kitahara, and K. Nagata, “Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells,” Cancer Research, vol. 60, no. 11, pp. 2942–2948, 2000. View at Google Scholar · View at Scopus